IDO1 and neoplasm: In the presence of IDO1, Trp was oxidized into N-formylkynurenine (F-Kyn), leading to the opening of channel gates of nanoparticles (Fig. 6a-II) and triggering the drug release specifically in tumor cells (Fig. 6a-III).